Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases

• Main Authors: Bruno Laganà (Author), Angelo Zullo (Author), Maria Lia Scribano (Author), Maria Sole Chimenti (Author), Alberto Migliore (Author), Andrea Picchianti Diamanti (Author), Roberto Lorenzetti (Author), Palma Scolieri (Author), Lorenzo Ridola (Author), Elena Ortona (Author), Marina Pierdominici (Author), Vincenzo Bruzzese (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Spondyloarthritis (SpA) and inflammatory bowel diseases (IBD) are chronic inflammatory diseases characterized by an aberrant immune response and inflammation with a key role for TNF in their pathogenesis. Accordingly, TNF-inhibiting therapy (TNFi) has dramatically improved the management of these di...